__NUXT_JSONP__("/drugs/Lucatumumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"903512-50-5",chebiId:b,chemicalFormula:b,definition:"A fully human monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. Lucatumumab binds to and inhibits CD40, thereby inhibiting CD40 ligand-induced cell proliferation and triggering cell lysis via antibody-dependent cellular cytotoxicity (ADCC) in cells overexpressing CD40. CD40, an integral membrane protein found on the surface of B lymphocytes, is a member of the tumor necrosis factor receptor superfamily and is highly expressed in a number of B-cell malignancies.",fdaUniiCode:"P0EP9VFC4R",identifier:"C48405",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129822","C133877"],synonyms:["Anti-CD40 Monoclonal Antibody CHIR-12.12","CHIR-12.12","HCD-122","LUCATUMUMAB",a,"Monoclonal Antibody CHIR-12.12"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLucatumumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Lucatumumab","","2021-10-30T13:40:12.743Z")));